Search This Blog

Friday, December 13, 2019

Monopar Therapeutics sets terms of downsized IPO

Monopar Therapeutics (MNPR) has filed a preliminary prospectus for an IPO of ~1.1M common shares at $8-10 per share.
Underwriters’ over-allotment will be an additional ~167K shares.
In September, it filed for an offering of ~4.4M shares at the same price range.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)